Alexion to Present at the 37th Annual J.P. Morgan Healthcare Conference

On January 2, 2019 Alexion Pharmaceuticals (Nasdaq: ALXN) reported that management will present at the (Press release, Alexion, JAN 2, 2019, View Source [SID1234532437])9 at 7:30 a.m., PT (Press release, Alexion, JAN 2, 2019, View Source [SID1234532437]). A breakout question and answer session will immediately follow the formal presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Audio webcasts of the presentation and breakout question and answer session will be available live. You can access the webcasts at: View Source An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.